1. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria Teresa; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Bronno; Zweegman, Sonja; Oliva, Stefania; van der Velden, Vincent H J; Zamagni, Elena; Palumbo, Giuseppe A; Patriarca, Francesca; Montefusco, Vittorio; Galli, M... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria Teresa; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Bronno; Zweegman, Sonja; Oliva, Stefania; van der Velden, Vincent H J; Zamagni, Elena; Palumbo, Giuseppe A; Patriarca, Francesca; Montefusco, Vittorio; Galli, M... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial. Issue 1 (January 2023) Authors: Mina, Roberto; Musto, Pellegrino; Rota-Scalabrini, Delia; Paris, Laura; Gamberi, Barbara; Palmas, Angelo; Aquino, Sara; de Fabritiis, Paolo; Giuliani, Nicola; De Rosa, Luca; Gozzetti, Alessandro; Cellini, Claudia; Bertamini, Luca; Capra, Andrea; Oddolo, Daniela; Vincelli, Iolanda Donatella; Ronco... Journal: Lancet oncology Issue: Volume 24:Issue 1(2023) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial. Issue 12 (December 2021) Authors: Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Ni... Journal: Lancet oncology Issue: Volume 22:Issue 12(2021) Page Start: 1705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19. Issue 23 (10th September 2020) Authors: Cattaneo, Chiara; Daffini, Rosa; Pagani, Chiara; Salvetti, Massimo; Mancini, Valentina; Borlenghi, Erika; D'Adda, Mariella; Oberti, Margherita; Paini, Anna; De Ciuceis, Carolina; Barbullushi, Kordelia; Cancelli, Valeria; Belotti, Angelo; Re, Alessandro; Motta, Marina; Peli, Annalisa; Bianchetti, ... Journal: Cancer Issue: Volume 126:Issue 23(2020) Page Start: 5069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial. Issue 6 (June 2021) Authors: Dimopoulos, Meletios A; Terpos, Evangelos; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Baldini, Luca; Symeonidis, Argiris; Bila, Jelena; Oriol, Albert; Mateos, Maria-Victoria; Einsele, Hermann; Orfanidis, Ioannis; Ahmadi, Tahamtan; Ukropec, Jon; Kampf... Journal: Lancet oncology Issue: Volume 22:Issue 6(2021) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials. Issue 4 (1st June 2022) Authors: Bruzzese, Antonella; Derudas, Daniele; Galli, Monica; Martino, Enrica Antonia; Rocco, Stefano; Conticello, Concetta; Califano, Catello; Giuliani, Nicola; Mangiacavalli, Silvia; Farina, Giuliana; Lombardo, Alessandra; Brunori, Marino; Rossi, Elena; Antonioli, Elisabetta; Ria, Roberto; Zambello, Re... Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: Kinetics of its appearance and potential predictive role in infectious complications. Issue 1 (January 2015) Authors: Belotti, Angelo; Duca, Lorena; Borin, Lorenza; Realini, Silvia; Renso, Rossella; Parma, Matteo; Pioltelli, Pietro; Pogliani, Enrico; Cappellini, Maria Domenica Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Predictive role of diffusion‐weighted whole‐body MRI (DW‐MRI) imaging response according to MY‐RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry. (15th July 2021) Authors: Belotti, Angelo; Ribolla, Rossella; Cancelli, Valeria; Villanacci, Alberta; Angelini, Valentina; Chiarini, Marco; Giustini, Viviana; Facchetti, Giulia V.; Roccaro, Aldo M.; Ferrari, Samantha; Peli, Annalisa; Bottelli, Chiara; Cattaneo, Chiara; Crippa, Claudia; Micilotta, Monica; Frittoli, Barbara... Journal: Cancer medicine Issue: Volume 10:Number 17(2021) Page Start: 5859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65‐75 years. Issue 7 (23rd April 2020) Authors: Belotti, Angelo; Ribolla, Rossella; Cancelli, Valeria; Crippa, Claudia; Bianchetti, Nicola; Ferrari, Samantha; Bottelli, Chiara; Cattaneo, Chiara; Tucci, Alessandra; De La Fuente Barrigon, Carmen; Rossi, Giuseppe Journal: American journal of hematology Issue: Volume 95:Issue 7(2020:Jul.) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗